Inhibition of MAPK p38alpha overcomes the cancer immunosurveillance defect caused by FPR1 loss-of-function mutation. (linkinghub.elsevier.com)

Authors: Pan Y … Kroemer G Journal: Cell Reports Medicine Published: 2026-03-17 DOI: https://doi.org/10.1016/j.xcrm.2026.102683